About us
SIS Medical AG´s mission is to be a premium supplier of medical devices by developing, producing and providing best-in class high-quality products for the minimally invasive treatment of endovascular lesions and to bring value to our customers and patients with the goal to achieve better quality of therapy.
Our dedicated Quality Policy ensures to fulfill our mission at highest possible level throughout 5 major pillars.
Customer
The policy is to deliver safe, effective and reliable products that bring value to the customer with the goal to build and keep long-term customer relationship through:
- Known and understood customer needs
- Active customer support and reliability
Company
We at SIS Medical AG ensure a long-term existence of our company by:
- A financial profitability approach through continuous improvement of the organization at all levels by
- Taking measures that our management system remains suitable, adequate and effective
Products
We want to save lives with our products through:
- Continuous improvement of our products
- Controlling and improving our processes according to technical progress
Employees
We support all our employees through adequate internal communication of company´s goals and trainings so that they are aware of the scope, responsibility and authority of their function and everyone´s impact on product quality. We want our employees to be highly committed and responsible through:
- Timely and honest information, two way communication and reaction to concerns of our employees
Regulatory Compliance
- We strive to comply with national and international laws and regulations
- We consider environmental issues important and strive to find solutions that are both ecological and economical
Founded in 2007 Winterthur, Switzerland. SIS Medical has always been and will still be dedicated to develop, produce and distribute innovative high performance PTCA Balloon Catheters which are designed to facilitate the daily work of the user, help to extent treatment options and to improve the quality of patients live.
Our target is to provide best in class devices for an optimal lesion preparation prior to stent (DES) implantation (including Scaffolds, BVS) in order to optimize long term clinical outcome.
We are convinced that our range of high and super high pressure PTCA balloons, like the BEO NC, low profile, high pressure balloon and the OPN NC super high pressure PTCA balloon (RBP 35 atm), incorporating an unique twin wall balloon construction, are the answer to successfully target unmet clinical needs, as for example, undilatable lesions, in-stent restenosis (ISR) aso…
In October 2015, the SHS Investment Group, Tübingen Germany; ((www.shs-capital.eu))has become the major shareholder of SIS Medical AG.
SHS, founded in 1993 is an independent private equity company, located in Tübingen, Germany with the focus on investments in the MedTech and Life Sciences sector. SHS, with it’s vast experience in this field is investing and supporting the development and growth of SIS Medical with the goal to transform a promising young company into a worldwide successfully operating entity.
As a first result of the new major shareholdership, SIS MEDICAL AG has moved in May 2016 to new facilities in Frauenfeld, Switzerland, establishing the base, for further successful growth with the target to become a leading company in the field of vascular interventions and to be represented worldwide.
SIS MEDICAL – Swiss Interventional Systems “On the move to new frontiers” has already become part of reality.
The success story is continuing. You are kindly invited to follow and become a part of it.